Dr. Heidebrink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
1ST floor Taubman CTR Recp C
Ann Arbor, MI 48109Phone+1 734-936-9010Fax+1 734-647-8535
Education & Training
University of MichiganResidency, Neurology, 1992 - 1995
Baylor University Medical CenterInternship, Internal Medicine, 1991 - 1992
University of Texas Southwestern Medical SchoolClass of 1991
Certifications & Licensure
MI State Medical License 1995 - 2026
TX State Medical License 1992 - 1993- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid Start of enrollment: 2020 Jul 14
Publications & Presentations
PubMed
- 350 citationsEffect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized TrialMaurice W. Dysken, Mary Sano, Sanjay Asthana, Julia E. Vertrees, Muralidhar Pallaki
JAMA. 2014-01-01 - 734 citationsEarly role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysisYasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21 - 33 citationsHigher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegenerationNicolai Franzmeier, M. Suárez-Calvet, Lukas Frontzkowski, Annah M. Moore, Timothy J. Hohman
Molecular Neurodegeneration. 2020-10-08
Press Mentions
11 Ways to Reduce Your Risk of DementiaAugust 21st, 2024- 10 Ways You Can Cut Your Risk for DementiaFebruary 25th, 2023
- 10 Ways to Reduce Your Risk of DementiaFebruary 20th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
